BREATH Committees
The Management Board, Steering Committee and the Scientific and Economic Advisory Board are the committees set up at BREATH to ensure a successful scientific and economic cooperation.
Management Board
The Management Board was elected on November 19, 2019 from the BREATH faculty for a third term of three years:
Prof. Dr. Gesine Hansen
Prof. Dr. Dr. Axel Haverich
Prof. Dr. Norbert Krug (ITEM)
Prof. Dr. Tobias Welte.
Prof. Dr. Tobias Welte also occupies the position of Site Director for Hannover within the DZL.
Steering Committee
The Steering Committee constitutes the highest decision-making committee in the BREATH research network and is made up of the Management Board
the Management Board
Prof. Dr. Tobias Welte
Prof. Dr. Gesine Hansen
Prof. Dr. Dr. Axel Haverich
Prof. Dr. Norbert Krug
the Managing Director
Dr. Annegret Zurawski
one member each from the disease areas Asthma und Allergic Diseases (AA) and Endstage Lung Diseases (ELD)
Prof. Dr. Jens Hohlfeld (Fraunhofer ITEM)
Prof. Dr. Ulrich Martin
one representative from the Platforms
Prof. Dr. Jens Vogel-Claussen
one respresentative from the partner LUH
Prof. Dr. Annika Herr
and a patient representative
Michael Wilken.
The above-named members of the Steering Committee were elected on November 19, 2019 in the BREATH General Assembly for a term of three years. Except of Michael Wilken, Prof. Dr. Herr and Prof. Dr. Voglewho is a new member of the committee, it is their third term.
The Steering Committee is responsible for decisions regarding the budget distribution guidelines, the admission of new members into the assembly of doctors and scientists (BREATH Faculty) and the strategic and organizational orientation of the research network. The promotion of young researchers also belongs to the functions of the Steering Committee.
Scientific and Economic Advisory Board
The International Scientific and Economic Advisory Board is currently made up of six members:
Chairman,
Prof. Dr. Andrew Bush Professor of Paediatric Respirology, Imperial College & Consultant Paediatric Chest Physician, Royal Brompton & Harefield NHS Foundation Trust, UK
Prof. Dr. Peter J. Sterk Head of Research, Department of Respiratory Diseases, Academic Medical Center, University of Amsterdam, The Netherlands
Prof. Dr. Thea Koch Klinikdirektorin, Klinik und Poliklinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Germany
Prof. Dr. Dirk Van Raemdonck Head of Clinic, Department of Thoracic Surgery, University Hospitals Leuven, Belgium
a representative of the pharmaceutical industry,
Dr. Cordula Mohrlang Senior Director Scientific Affairs, GlaxoSmithKline GmbH & Co. KG, Munich, Germany
and a representative from a medical insurance company.
Dr. Christoph Vauth Deputy Chairman of the Executive Board, AOK NordWest, Die Gesundheitskasse, Dortmund, Germany
The Advisory Board oversees the scientific and medically innovative progress of BREATH and supports the BREATH Faculty in an advisory capacity. This important function is an honorary position.